Chinese Journal of Dermatology ›› 2022, Vol. 55 ›› Issue (11): 969-975.doi: 10.35541/cjd.20220120
• Original Articles • Previous Articles Next Articles
Pan Haihao1,2, Li Yingyi1, Qin Yao1, Wen Yujie1, Lai Pan1, Xiong Shan1, Cao Mengzhou1, Sun Jingru1, Tu Ping1, Wang Yang1
Received:
2022-02-24
Revised:
2022-08-18
Online:
2022-11-15
Published:
2022-11-03
Contact:
Wang Yang
E-mail:yangwang_dr@gmail.com
Supported by:
Pan Haihao, Li Yingyi, Qin Yao, Wen Yujie, Lai Pan, Xiong Shan, Cao Mengzhou, Sun Jingru, Tu Ping, Wang Yang. Correlations between pruritus and CC chemokine ligand 17 in patients with mycosis fungoides[J]. Chinese Journal of Dermatology, 2022, 55(11): 969-975.doi:10.35541/cjd.20220120
[1] | Willemze R, Jaffe ES, Burg G, et al. WHO⁃EORTC classification for cutaneous lymphomas[J]. Blood, 2005,105(10):3768⁃3785. doi: 10.1182/blood⁃2004⁃09⁃3502. |
[2] | Scarisbrick JJ, Bagot M, Ortiz⁃Romero PL. The changing therapeutic landscape, burden of disease, and unmet needs in patients with cutaneous T⁃cell lymphoma[J]. Br J Haematol, 2021,192(4):683⁃696. doi: 10.1111/bjh.17117. |
[3] | Beynon T, Radcliffe E, Child F, et al. What are the supportive and palliative care needs of patients with cutaneous T⁃cell lymphoma and their caregivers? A systematic review of the evidence[J]. Br J Dermatol, 2014,170(3):599⁃608. doi: 10.1111/ bjd.12644. |
[4] | Vij A, Duvic M. Prevalence and severity of pruritus in cutaneous T cell lymphoma[J]. Int J Dermatol, 2012,51(8):930⁃934. doi: 10.1111/j.1365⁃4632.2011.05188.x. |
[5] | Wright A, Wijeratne A, Hung T, et al. Prevalence and severity of pruritus and quality of life in patients with cutaneous T⁃cell lymphoma[J]. J Pain Symptom Manage, 2013,45(1):114⁃119. doi: 10.1016/j.jpainsymman.2012.01.012. |
[6] | Beynon T, Selman L, Radcliffe E, et al. ′We had to change to single beds because I itch in the night′: a qualitative study of the experiences, attitudes and approaches to coping of patients with cutaneous T⁃cell lymphoma[J]. Br J Dermatol, 2015,173(1):83⁃92. doi: 10.1111/bjd.13732. |
[7] | Meyer N, Paul C, Misery L. Pruritus in cutaneous T⁃cell lymphomas: frequent, often severe and difficult to treat[J]. Acta Derm Venereol, 2010,90(1):12⁃17. doi: 10.2340/00015555⁃0789. |
[8] | Serrano L, Martinez⁃Escala ME, Zhou XA, et al. Pruritus in cutaneous T⁃cell lymphoma and its management[J]. Dermatol Clin, 2018,36(3):245⁃258. doi: 10.1016/j.det.2018.02.011. |
[9] | Olsen E, Vonderheid E, Pimpinelli N, et al. Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC)[J]. Blood, 2007,110(6):1713⁃1722. doi: 10.1182/blood⁃2007⁃03⁃055749. |
[10] | Jawed SI, Myskowski PL, Horwitz S, et al. Primary cutaneous T⁃cell lymphoma (mycosis fungoides and Sézary syndrome): part II. Prognosis, management, and future directions[J]. J Am Acad Dermatol, 2014,70(2):223.e1⁃e17; quiz 240⁃242. doi: 10.1016/j.jaad.2013.08.033. |
[11] | Liu F, Gao Y, Xu B, et al. PEG10 amplification at 7q21.3 potentiates large⁃cell transformation in cutaneous T⁃cell lymphoma[J]. Blood, 2022,139(4):554⁃571. doi: 10.1182/blood. 2021012091. |
[12] | Phan NQ, Blome C, Fritz F, et al. Assessment of pruritus intensity: prospective study on validity and reliability of the visual analogue scale, numerical rating scale and verbal rating scale in 471 patients with chronic pruritus[J]. Acta Derm Venereol, 2012,92(5):502⁃507. doi: 10.2340/00015555⁃1246. |
[13] | Varghese F, Bukhari AB, Malhotra R, et al. IHC profiler: an open source plugin for the quantitative evaluation and automated scoring of immunohistochemistry images of human tissue samples[J]. PLoS One, 2014,9(5):e96801. doi: 10.1371/journal.pone.0096801. |
[14] | Seyed Jafari SM, Hunger RE. IHC optical density score: a new practical method for quantitative immunohistochemistry image analysis[J]. Appl Immunohistochem Mol Morphol, 2017,25(1):e12⁃e13. doi: 10.1097/PAI.0000000000000370. |
[15] | Feld M, Garcia R, Buddenkotte J, et al. The pruritus⁃ and TH2⁃associated cytokine IL⁃31 promotes growth of sensory nerves[J]. J Allergy Clin Immunol, 2016,138(2):500⁃508.e24. doi: 10. 1016/j.jaci.2016.02.020. |
[16] | Saeki H, Tamaki K. Thymus and activation regulated chemokine (TARC)/CCL17 and skin diseases[J]. J Dermatol Sci, 2006,43(2):75⁃84. doi: 10.1016/j.jdermsci.2006.06.002. |
[17] | Yoshie O, Matsushima K. CCR4 and its ligands: from bench to bedside[J]. Int Immunol, 2015,27(1):11⁃20. doi: 10.1093/intimm/dxu079. |
[18] | Ferenczi K, Fuhlbrigge RC, Pinkus J, et al. Increased CCR4 expression in cutaneous T cell lymphoma[J]. J Invest Dermatol, 2002,119(6):1405⁃1410. doi: 10.1046/j.1523⁃1747.2002.19610.x. |
[19] | Hoeller C, Richardson SK, Ng LG, et al. In vivo imaging of cutaneous T⁃cell lymphoma migration to the skin[J]. Cancer Res, 2009,69(7):2704⁃2708. doi: 10.1158/0008⁃5472.CAN⁃08⁃2891. |
[20] | Kimura T, Sugaya M, Suga H, et al. Variations in serum TARC and I⁃TAC levels reflect minor changes in disease activity and pruritus in atopic dermatitis[J]. Acta Derm Venereol, 2014,94(3):331⁃332. doi: 10.2340/00015555⁃1709. |
[21] | Furue M, Ulzii D, Vu YH, et al. Pathogenesis of atopic dermatitis: current paradigm[J]. Iran J Immunol, 2019,16(2):97⁃107. doi: 10.22034/IJI.2019.80253. |
[22] | Cedeno⁃Laurent F, Singer EM, Wysocka M, et al. Improved pruritus correlates with lower levels of IL⁃31 in CTCL patients under different therapeutic modalities[J]. Clin Immunol, 2015,158(1):1⁃7. doi: 10.1016/j.clim.2015.02.014. |
[23] | Nattkemper LA, Martinez⁃Escala ME, Gelman AB, et al. Cutaneous T⁃cell lymphoma and pruritus: the expression of IL⁃31 and its receptors in the skin[J]. Acta Derm Venereol, 2016,96(7):894⁃898. doi: 10.2340/00015555⁃2417. |
[24] | Singer EM, Shin DB, Nattkemper LA, et al. IL⁃31 is produced by the malignant T⁃cell population in cutaneous T⁃Cell lymphoma and correlates with CTCL pruritus[J]. J Invest Dermatol, 2013,133(12):2783⁃2785. doi: 10.1038/jid.2013.227. |
[25] | Abou El⁃Ela M, Ael⁃A E, Fawzi M, et al. Thymus and activation⁃regulated chemokine in different stages of mycosis fungoides: tissue and serum levels[J]. Australas J Dermatol, 2011,52(3):167⁃171. doi: 10.1111/j.1440⁃0960.2010.00688.x. |
[1] | Zheng Jiayuan, Yu Bingqian, Chen Xianxia, Luo Zhicheng. Characteristics of pruritus in adult patients with psoriasis vulgaris and its effect on quality of life [J]. Chinese Journal of Dermatology, 2022, 55(9): 790-794. |
[2] | Wen Guangdong, Mao Dandan, Zhang Yuanyuan, Dou Yuanqing, Zhao Pei, Wu Chenyu, Zhang Jianzhong. A case of generalized lichen amyloidosis treated with dupilumab: the first case reported in China [J]. Chinese Journal of Dermatology, 2022, 55(6): 508-510. |
[3] | Wang Ao, Yao Xu. Mechanisms of pruritus in atopic dermatitis [J]. Chinese Journal of Dermatology, 2022, 55(4): 357-361. |
[4] | Wang Jiaqi, Wang Ping, Li Liuyu, Fan Qimin, Zhu Mengyan, Wang Yanqing, Zhou Hongyu, Shen Hong, Xu Ai′e. Cutaneous hypopigmented lymphoproliferative disorders: a clinicopathological study of 41 cases [J]. Chinese Journal of Dermatology, 2022, 55(2): 110-115. |
[5] | Lin Yuchieh, Liu Fengjie, Gao Yumei, Liu Xiangjun, Xu Bufang, Li Yingyi, Lai Pan, Chen Zhuojing, Sun Jingru, Tu Ping, Wang Yang. Significance of lysophosphatidic acid receptor 6 in the large-cell transformation of mycosis fungoides and its effect on the proliferation and apoptosis of cutaneous T-cell lymphoma cells [J]. Chinese Journal of Dermatology, 2022, 55(2): 102-109. |
[6] | Dermatology Professional Committee of Chinese Research Hospital Society, China Dermatologist Association. Clinical application of ultraviolet A1 in dermatology: an expert consensus statement (2022) [J]. Chinese Journal of Dermatology, 2022, 55(11): 956-961. |
[7] | Li Yan, Xiang Lujing, Li Ming, Lei Mingjun, Tian Zan, Yuan Jianguo, Zhou Hong, Liu Ying, Wang Jie, Chen Jinguang, Wang Ting, Gao Shuangshuang, Zhang Yu, Li Linfeng. Efficacy of a skin care ointment containing oligomeric maltose X in the adjuvant treatment of pruritus in patients with mild to moderate eczema: a multicenter, randomized, double-blind controlled clinical study [J]. Chinese Journal of Dermatology, 2022, 55(11): 1021-1025. |
[8] | Group on Medical Aesthetics and Cosmetology, Chinese Academy of Aesthetic Medicine. Management of scalp health: a Chinese expert consensus statement (2022) [J]. Chinese Journal of Dermatology, 2022, 55(10): 843-849. |
[9] | Kailibinuer·Abulikemu, Liang Junqin. Mechanisms of pruritus in bullous pemphigoid [J]. Chinese Journal of Dermatology, 2022, 55(10): 919-921. |
[10] | Cheng Bihong, Dou Xia. Diagnosis and classification of chronic prurigo [J]. Chinese Journal of Dermatology, 2022, 0(1): 20210130-e20210130. |
[11] | Zhang Ying, Gan Lu, Li Siqi, Li Yan, Song Hao, Shao Xuebao, Zhang Wei, Xu Xiulian, Jiang Yiqun, Zeng Xuesi, Chen Hao, Sun Jianfang. Clinicopathological and immunophenotypic analysis of 24 cases of transformed mycosis fungoides [J]. Chinese Journal of Dermatology, 2022, 55(1): 20-26. |
[12] | Guo Lan, Jin Hongzhong. Small-molecule/biological agents in the treatment of pruritus [J]. Chinese Journal of Dermatology, 2022, 0(1): 20210582-e20210582. |
[13] | Zhang Ying, Li Siqi, Gan Lu, Kong Yingqi, Li Yan, Chen Hao, Sun Jianfang. Role of flow cytometric analysis of peripheral blood in the diagnosis of lymphoma-associated erythroderma [J]. Chinese Journal of Dermatology, 2021, 54(9): 808-813. |
[14] | Committee on Allergic Diseases, China Dermatologist Association, Atopic Dermatitis Research Center, Chinese Society of Dermatology, Dermatology Branch of China International Exchange and Promotion Association for Medical and Healthcare. Expert consensus for management of itch in atopic dermatitis [J]. Chinese Journal of Dermatology, 2021, 54(5): 391-396. |
[15] | Liu Fengjie, Tu Ping, Wang Yang. Molecular genetic pathogenesis of mycosis fungoides [J]. Chinese Journal of Dermatology, 2021, 54(2): 174-178. |
|